Mechanistically, it might induce glioma cell apoptosis through ERK1/2-mediated mitochondrial dysfunction and control glioma cell growth by modulating wild-type p53 activation or mutant p53 inhibition [154]. This evidence concerns the gene MAPK3 and central nervous system cancer.